Skip to content
MedsAcross

Medicine

Solu-medrol 500 mg/mL powder for injection

Methylprednisolone · Intramuscular, intravenous · Pharmacia & Upjohn
Available on requestPrescription onlyUS FDA

Solu-medrol 500 mg/mL powder for injection is a prescription medicine containing Methylprednisolone for intramuscular, intravenous use, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store unreconstituted product at controlled room temperature 20° to 25°C (68°…

Key facts

Active ingredient (INN)
Methylprednisolone
Brand
Solu-medrol
Strength
500 mg/mL
Dosage form
Powder for injection
Route
Intramuscular, intravenous
Packs
1 vial
Marketing authorisation holder
Pharmacia & Upjohn
Manufacturer
Pharmacia & Upjohn
Origin register
US FDA, United States
Storage
Store unreconstituted product at controlled room temperature 20° to 25°C (68° to 77°F). Store reconstituted solution (not further diluted) at controlled room temperature 20° to 25°C (68° to 77°F), and use it within 48 hours. See section DOSAGE AND ADMINISTRATION, for storage of further diluted solution.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D07AA01 Methylprednisolone
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 April 1959
Identifiers
RxCUI 207191, 207193, 311659 +7DailyMed set ID cd99be87-c8d9-48d6-a8e5-e081052e3f19NDC 0009-0758Application NDA011856

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial in 1 carton / 8 mL in 1 vial0009-0758-01Pharmacia & Upjohn2 April 1959

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 October 1957Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Methylprednisolone

Clinical summary

Methylprednisolone is a corticosteroid indicated in conditions. It is available as tablets, powder for injection and injectable suspension for intramuscular, intravenous and oral use. MedsAcross supplies Methylprednisolone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Methylprednisolone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Solu-medrol 500 mg/mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.